A. Alan Musso's Insider Trades & SAST Disclosures

A. Alan Musso's most recent trade in Fulcrum Therapeutics Inc was a trade of 170,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 2, 2026.

Share

Note

This is a custom search result for pattern A. Alan Musso.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Fulcrum Therapeutics Inc	Alan A. Musso	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Feb 2026	170,000	170,000	-		-	Stock Option (right to buy)
Rein Therapeutics Inc	Alan A. Musso	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jul 2025	17,500	17,500	-		-	Stock Option (right to buy)
Fulcrum Therapeutics Inc	Alan A. Musso	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jan 2025	285,000	285,000	-		-	Stock Option (right to buy)
Rein Therapeutics Inc	Alan A. Musso	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Dec 2024	35,000	35,000	-		-	Stock Option (right to buy)
Rein Therapeutics Inc	Alan A. Musso	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Aug 2024	2,725	2,725	-		-	Stock Option (right to buy)
Fulcrum Therapeutics Inc	A. Alan Musso	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2024	100,000	100,000	-		-	Stock Option (right to buy)
Fulcrum Therapeutics Inc	Alan Musso A.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2024	61,822	61,822	-		-	Stock Option (right to buy)
Fulcrum Therapeutics Inc	Alan A. Musso	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Aug 2023	432,800	432,800	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades